Volume 31, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



infections in mice provide models for the study of non-healing leishmanial infections similar to diffuse cutaneous leishmaniasis (DCL) in man. BALB/c mice infected with developed large non-healing primary lesions as well as multiple metastatic lesions on the feet, face and ears. This susceptibility was not dose- or route-dependent. In contrast, C57BL/6 mice, when inoculated intradermally (ID), developed cutaneous lesions which healed. However, when the normally resistant C57BL/6 mice were inoculated intravenously (IV), they developed multiple non-healing lesions which resembled the infection seen in susceptible BALB/c mice. Thus, non-healing leishmanial infections similar to those of human DCL can be produced in both a genetically susceptible (BALB/c) and resistant (C57BL/6) strain of mouse. Although the eventual outcome of the infection is similar in BALB/c and IV inoculated C57BL/6 mice, the immunological parameters of the infection in the two models differed significantly. infection in BALB/c mice was associated with a non-specific immunodepression, as assessed by lymphocyte proliferative responses to concanavalin A, phytohemagglutinin and lipopolysaccharide. In contrast, no evidence of generalized immunodepression was observed in the IV-inoculated, non-healing C57BL/6 mice. These two models also differed in their ability to express a delayed skin response to leishmanial antigen during infection. BALB/c mice were capable of mounting a transient delayed skin response, while IV-inoculated C57BL/6 mice developed no detectable delayed hypersensitivity. Both non-healing and healing infections were accompanied by the development of specific indirect immunofluorescent antibody, although the titers were significantly higher in non-healing infections. Spleen cells from infected BALB/c and C57BL/6 (ID- or IV-inoculated) mice responded to leishmanial antigen in a lymphocyte transformation assay. In BALB/c mice the ability to respond to antigen could be demonstrated throughout the course of infection; however, non-healing C57BL/6 mice developed a suppressor cell late in the infection which suppressed leishmanial antigen responses.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error